Going, Going, Nearly Gone… Grade A Biotech Offer Selling Out
Going, going, going, almost gone… Closing when filled, 93 per cent of biotech company Regenall is now bid for. The company is seeking £100,000, and is at the cutting edge of biotech and cosmesis, led by one of the UK’s most eminent surgeons. The company is risk-rated A, and offers a gross yield of […]